{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:10:46Z","timestamp":1764587446402},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,15]]},"DOI":"10.1097\/tp.0b013e318176ae2c","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T19:40:54Z","timestamp":1236282054000},"page":"96-103","source":"Crossref","is-referenced-by-count":56,"title":["Renal Transplantation in Patients With Positive Lymphocytotoxicity Crossmatches: One Center\u2019s Experience"],"prefix":"10.1097","volume":"86","author":[{"given":"Colm C.","family":"Magee","sequence":"first","affiliation":[]},{"given":"Joana","family":"Felgueiras","sequence":"additional","affiliation":[]},{"given":"Kathryn","family":"Tinckam","sequence":"additional","affiliation":[]},{"given":"Sayeed","family":"Malek","sequence":"additional","affiliation":[]},{"given":"Helen","family":"Mah","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Tullius","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1432-2277.2005.00257.x","article-title":"Transplantation across previously incompatible immunological barriers.","volume":"19","author":"Magee","year":"2006","journal-title":"Transpl Int"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/01.TP.0000084200.40159.EC","article-title":"Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.","volume":"76","author":"Akalin","year":"2003","journal-title":"Transplantation"},{"key":"R3-17-20210129","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation.","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg).","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3046.2004.00214.x","article-title":"Transplanting patients with a positive donor-specific crossmatch: A single center\u2019s perspective.","volume":"8","author":"Montgomery","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00007890-200011270-00023","article-title":"A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants.","volume":"70","author":"Schweitzer","year":"2000","journal-title":"Transplantation"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014An addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation.","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"R13-17-20210129","first-page":".1.c.11","article-title":"ASHI Laboratory Manual.","author":"Hopkins","year":"2000"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199901270-00012","article-title":"The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.","volume":"67","author":"Przybylowski","year":"1999","journal-title":"Transplantation"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.humimm.2004.06.001","article-title":"Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.","volume":"65","author":"Bearden","year":"2004","journal-title":"Hum Immunol"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.humimm.2004.09.010","article-title":"ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.","volume":"65","author":"Tinckam","year":"2004","journal-title":"Hum Immunol"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.TP.0000090868.88895.E0","article-title":"Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.","volume":"76","author":"Zachary","year":"2003","journal-title":"Transplantation"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R20-17-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ndt\/gfl696","article-title":"Successful living donor kidney transplantation across HLA and ABO incompatibilities.","volume":"22","author":"Magee","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R21-17-20210129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1600-6143.2006.01699.x","article-title":"Kidney transplantation in patients with antibodies against donor HLA class II.","volume":"7","author":"Pollinger","year":"2007","journal-title":"Am J Transplant"},{"issue":"5 Suppl","key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jaad.2006.04.061","article-title":"Nephrogenic fibrosing dermopathy with recurrence after allograft failure.","volume":"56","author":"Goddard","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R23-17-20210129","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1600-6143.2006.01393.x","article-title":"IVIG vs. plasmapheresis for desensitization: Which is better?","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant"},{"key":"R24-17-20210129","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1600-6143.2006.01472.x","article-title":"Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG.","volume":"6","author":"Vo","year":"2006","journal-title":"Am J Transplant"},{"key":"R25-17-20210129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/sj.leu.2404359","article-title":"Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.","volume":"20","author":"Timm","year":"2006","journal-title":"Leukemia"},{"key":"R26-17-20210129","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.tp.0000244063.05338.27","article-title":"B-cell activity of polyclonal antithymocyte globulins.","volume":"82","author":"Zand","year":"2006","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200807150-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:32:14Z","timestamp":1618277534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200807150-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318176ae2c","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7,15]]}}}